New cancer clinical trial: FID-007 in Treating Participants With Advanced Solid Tumors

Published on: May 25, 2018 at 12:00PM
Conditions:   Advanced Malignant Solid Neoplasm;   Refractory Malignant Solid Neoplasm
Interventions:   Other: Laboratory Biomarker Analysis;   Drug: PEOX-based Polymer Encapsulated Paclitaxel FID-007;   Other: Pharmacokinetic Study
Sponsors:   University of Southern California;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2krAVyL